[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Antalya Training and Research Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":291},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,10,0,[8,47,80,108,134,162,193,215,246,271],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100635896","effects-of-stellate-ganglion-block-on-delirium-and-circadian-rhythm-in-geriatric-intensive-care-patients-100635896",false,"NCT07558642","Effects of Stellate Ganglion Block on Delirium and Circadian Rhythm in Geriatric Intensive Care Patients","Effects of Stellate Ganglion Block on Delirium and Circadian Rhythm in Geriatric Intensive Care Patients: A Prospective Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients aged 65 years or older expected to remain in the intensive care unit for more than 48 hours\n* RASS score \\> -4\n\nExclusion Criteria:\n\n* History of neurodegenerative disease (e.g., Alzheimer's disease, dementia, vascular dementia)\n* Uncontrolled psychiatric disorders\n* Alcohol use disorder and\u002For substance abuse\n* History of traumatic brain injury or ischemic\u002Fhemorrhagic cerebrovascular event\n* Severe hearing and\u002For visual impairment\n* Benzodiazepine use\n* Renal failure (Acute Kidney Injury stage 2-3) and\u002For liver failure\n* Beta-blocker use\n* Contraindications to stellate ganglion block (e.g., coagulopathy, glaucoma, recent myocardial infarction)\n* Sepsis\n* Allergy to bupivacaine\n* Inability to communicate in Turkish or English\n* Severe hyponatremia\n* Hemodynamic instability","ALL","65 Years","99 Years",{"count":20,"type":21},130,"ESTIMATED","INTERVENTIONAL",[24],"NA","Delirium is a common complication in elderly intensive care unit (ICU) patients and is associated with poor clinical outcomes. Circadian rhythm disruption is considered an important contributing factor in delirium development. Stellate ganglion block (SGB) may modulate autonomic nervous system activity and improve circadian rhythm regulation.\n\nThis prospective randomized placebo-controlled trial aims to evaluate the effects of ultrasound-guided stellate ganglion block on delirium incidence and circadian rhythm in ICU patients aged 65 years and older. Delirium will be assessed using validated clinical scales, and circadian rhythm will be evaluated through serial measurements of serum melatonin and plasma cortisol levels",[27],"Stellate Ganglion Block",[27,29,30,31,32,33],"Delirium","Intensive Care Unit","Circadian Rhythm","Melatonin","Cortisol","NOT_YET_RECRUITING","2026-05-11",{"date":37,"type":38},"2026-05-13","ACTUAL",{"date":40,"type":21},"2026-05-06",{"date":42,"type":21},"2027-02-01",{"name":44,"class":45},"Antalya Training and Research Hospital","OTHER_GOV",2,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":59,"conditions":60,"keywords":66,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":73,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},"100638881","the-impact-of-video-assisted-thoracic-surgery-and-regional-anaesthesia-on-postoperative-opioid-consumption-and-pain-scores-100638881","NCT07578545","The Impact of Video-assisted Thoracic Surgery and Regional Anaesthesia on Postoperative Opioid Consumption and Pain Scores","The Effect of Paravertebral Block, Intertransverse Block, and Erector Spinae Plane Block on Postoperative Opioid Consumption and Pain Scores in Video-assisted Thoracic Surgery: a Prospective Observational Study","Inclusion Criteria:\n\n* aged 18-75 years\n* American Society of Anaesthesiology (ASA) score I-III\n* body mass index (BMI) \\\u003C35kg\u002Fm2\n* scheduled for elective VATS\n\nExclusion Criteria:\n\n* ASA score ≥4\n* BMI ≥35 kg\u002Fm2\n* declining to give written informed consent\n* controendications for block application\n* inability to undergo block application\n* history neurological disease or peripheral nerve disease\n* history of chronic opioid use\n* history of severe liver or kidney failure\n* patients admitted to the intensive care unit postoperatively intubated","18 Years","75 Years",{"count":57,"type":21},96,"OBSERVATIONAL","This present study aims is to compare the effects of ultrasound-guided paravertebral block, intertransverse process block, and erector spinae plane block on postoperative opioid consumption, and pain scores in patients undergoing VATS.",[61,62,63,64,65],"Thoracic Surgery","Videoassisted Thoracoscopic Surgery,One-lung Ventilation","Regional Anaesthesia","Postoperative Analgesia","Pain Score",[67,68,69,70,71],"videoassisted thoracoscopic surgery","regional anaesthesia","postoperative analgesia","chronic pain","quality of recovery","RECRUITING",{"date":35,"type":38},{"date":75,"type":38},"2026-05-04",{"date":77,"type":21},"2026-11-04",{"name":44,"class":45},1,{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":4,"eligibilityCriteria":86,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":17,"enrollmentInfo":87,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":89,"conditions":90,"keywords":96,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":102,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":79},"100635509","the-effects-of-regional-anaesthesia-techniques-on-hemidiaphragm-paralysis-postoperative-recovery-quality-opioid-consumption-and-pain-scores-100635509","NCT07553611","The Effects of Regional Anaesthesia Techniques on Hemidiaphragm Paralysis, Postoperative Recovery Quality, Opioid Consumption, and Pain Scores","Comparion of the Effects of Ultrasound-guided Interscalene Block, Erector Spinae Plane Block, Costoclavicular Block, and Supraclavicular Block on Hemidiaphragm Paralysis, Postoperative Recovery Quality, Opioid Consumption, and Pain Scores in Patients Undergoing Arthroscopic Shoulder Surgery: a Prospective Observational Trial","Inclusion Criteria:\n\n* aged 18-65 years\n* American Society of Anaesthesiology (ASA) score I-III\n* body mass index (BMI) \\\u003C30kg\u002Fm2\n* scheduled for elective arthroscopic surgery\n\nExclusion Criteria:\n\n* ASA score ≥4\n* BMI ≥30 kg\u002Fm2\n* declining to give written informed consent\n* controendications for block application\n* history of mental or neurological disease, severe liver and\u002For kidney disease\n* history of moderate or severe pulmonary disease\n* abnormal preoperative chest X-ray findings\n* scheduled for emergency surgery",{"count":88,"type":21},88,"This study aims to evaluate the effects of ultrasound-guided interscalene, erector spinae plane, costoclavicular, and supraclavicular blocks on hemidiaphragmatic paralysis, postoperative recovery quality, opioid consumption, and pain scores.",[63,91,92,93,94,95],"Arthroscopic Shoulder Surgery","Hemidiaphragmatic Paralysis","Recovery Quality","Opioid Consumption","Postoperative Pain Score",[68,97,98,99,100,101],"arthroscopic shoulder surgery","hemidiaphragmatic paralysis","recovery quality","opioid consumption","postoperative pain score",{"date":35,"type":38},{"date":104,"type":38},"2026-04-21",{"date":106,"type":21},"2026-11-21",{"name":44,"class":45},{"id":109,"slug":110,"hasResults":11,"nctId":111,"briefTitle":112,"officialTitle":113,"acronym":4,"eligibilityCriteria":114,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":4,"enrollmentInfo":115,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":117,"conditions":118,"keywords":123,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":133},"100614423","trimpact-real-world-first-line-atezolizumab-use-in-stage-iv-nsclc-with-pd-l1-50-100614423","NCT07279402","TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%","TRIMPACT: A Prospective Real-World Study of Atezolizumab Monotherapy as First-Line (Stage IV) Treatment in Patients With Non-Small Cell Lung Cancer With PD-L1 Tumor Cell Expression ≥50% and No Targetable Mutations","Inclusion Criteria:\n\n* Signed informed consent form.\n* Diagnosis of stage IV non-small cell lung cancer.\n* Male or female patients aged 18 years or older.\n* Patients who have been prescribed atezolizumab in accordance with routine clinical practice and the locally approved indication in Türkiye.\n* Patients who have received up to 3 cycles of atezolizumab at the screening visit.\n\nExclusion Criteria:\n\n* Patients who are not receiving atezolizumab for the treatment of lung cancer according to standard of care and the approved indication.\n* Known or suspected hypersensitivity to atezolizumab.\n* Pregnant or breastfeeding women.",{"count":116,"type":21},150,"This prospective, multicenter, real-world observational study aims to evaluate the clinical outcomes of first-line atezolizumab monotherapy in patients with stage IV non-small cell lung cancer (NSCLC) with PD-L1 tumor cell expression ≥50% and no targetable mutations. The study aim to determine how atezolizumab performs in routine clinical practice with respect to survival, treatment response, and safety outcomes in this patient population in Türkiye.",[119,120,121,122],"NSCLC Stage IV","PD-L1 Gene Mutation","Atezolizumab","Real World Study",[124],"NSCLC, PD-L1, Atezolizumab, Real World","2026-04-29",{"date":127,"type":38},"2026-04-30",{"date":129,"type":38},"2025-09-15",{"date":131,"type":21},"2027-10-01",{"name":44,"class":45},25,{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":139,"acronym":4,"eligibilityCriteria":140,"healthyVolunteers":11,"sex":141,"minAge":54,"maxAge":55,"enrollmentInfo":142,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":144,"conditions":145,"keywords":148,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":154,"lastUpdatePostDateStruct":155,"startDateStruct":157,"completionDateStruct":159,"leadSponsor":161,"locationsCount":79},"100631178","ultrasound-assessment-of-femoral-vein-and-inferior-vena-cava-collapsibility-to-predict-spinal-anesthesia-induced-hypotension-100631178","NCT07497295","Ultrasound Assessment of Femoral Vein and Inferior Vena Cava Collapsibility to Predict Spinal Anesthesia-Induced Hypotension","Evaluation of Inferior Vena Cava and Femoral Vein Collapsibility Indices for Predicting Post-Spinal Hypotension in Patients Undergoing Transurethral Prostate Resection: A Prospective Observational Study","Inclusion Criteria:\n\n* Adult patients aged 18-75 years\n* American Society of Anesthesiologists (ASA) physical status I-III\n* Scheduled for elective transurethral resection of the prostate (TUR-P)\n* Planned spinal anesthesia\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Refusal to participate in the study\n* Body mass index (BMI) \\>30 kg\u002Fm²\n* Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers\n* Emergency surgery\n* Baseline systolic arterial blood pressure \\\u003C90 mmHg or mean arterial pressure \\\u003C70 mmHg\n* Major peripheral vascular disease or severe cardiovascular disease\n* Unstable angina or left ventricular ejection fraction \\\u003C40%\n* Chronic respiratory disease\n* Increased intra-abdominal pressure\n* Autonomic nervous system disorders\n* Implanted pacemaker or implantable cardioverter-defibrillator\n* Anticipated difficult airway\n* Cognitive impairment or inability to cooperate","MALE",{"count":143,"type":21},110,"Spinal anesthesia is commonly used in transurethral prostate resection (TUR-P) surgeries; however, post-spinal hypotension remains a frequent and clinically significant complication, particularly in elderly patients. Early prediction of hypotension may allow timely interventions and improve patient safety.\n\nThis prospective observational study aims to evaluate the predictive value of preoperative ultrasound-based inferior vena cava collapsibility index (IVC-CI) and femoral vein collapsibility index (FVCI) for post-spinal hypotension in patients undergoing elective TUR-P under spinal anesthesia. Before spinal anesthesia, IVC and femoral vein measurements will be obtained using ultrasonography. Hemodynamic parameters will be recorded before and after spinal anesthesia, and the occurrence of hypotension will be assessed according to predefined criteria.\n\nThe study seeks to compare the diagnostic performance of IVC-CI and FVCI in predicting post-spinal hypotension and to identify potential clinical predictors associated with hypotension in this patient population.",[146,147],"Post Spinal Anaesthesia Hypotension","Transurethral Resection of the Prostate (TURP)",[149,150,151,152,153],"Spinal Anesthesia","Post-Spinal Hypotension","Ultrasonography","Inferior Vena Cava Collapsibility Index","Femoral Vein Collapsibility Index","2026-03-23",{"date":156,"type":38},"2026-03-27",{"date":158,"type":38},"2026-01-01",{"date":160,"type":21},"2026-05-30",{"name":44,"class":45},{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":167,"acronym":4,"eligibilityCriteria":168,"healthyVolunteers":11,"sex":16,"minAge":169,"maxAge":170,"enrollmentInfo":171,"targetDuration":4,"studyType":22,"phases":173,"briefSummary":174,"conditions":175,"keywords":180,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":185,"lastUpdatePostDateStruct":186,"startDateStruct":188,"completionDateStruct":190,"leadSponsor":192,"locationsCount":79},"100627821","effect-of-aiartificial-intelligence-based-storytelling-video-on-anxiety-and-fear-during-skin-prick-test-in-children-100627821","NCT07453615","Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children","AI-Based Video-Mediated Cognitive Preparation in Skin Prick Testing: A Prospective, Randomized Controlled Trial","Inclusion Criteria:\n\n* Children aged between 4 and 10 years (from 4th birthday to 11th birthday).\n* Children undergoing a Skin Prick Test (SPT) for the first time.\n* Presence of suspected Allergic Rhinitis and\u002For Asthma.\n* Cognitive ability to understand Turkish, follow the video story, and interpret visual assessment scales.\n* Parents with internet access to view the digital content.\n* Obtained parental informed consent and child assent (for ages 7 and above)\n\nExclusion Criteria:\n\n* Previous experience with Skin Prick Testing or a history of frequent medical procedures (e.g., frequent blood draws, surgeries) due to chronic illness.\n* Diagnosed with Autism Spectrum Disorder, severe ADHD(attention deficit hyperactivity disorder), intellectual disability, or severe psychiatric conditions preventing cooperation.\n* Significant visual or hearing impairments that prevent engagement with the video content.\n* Use of anxiolytics, sedatives, or medications affecting cognitive functions within the last 24 hours.\n* Chronic health problems (e.g., malignancy, immunodeficiency) that may elevate baseline anxiety levels.\n* Patients undergoing SPT for suspected Food Allergy, Drug Allergy, or Bee Venom Allergy.\n* For the intervention group: Failure to watch the video or answering the three \"validation questions\" incorrectly on the procedure day.","4 Years","10 Years",{"count":172,"type":21},100,[24],"This study evaluates the effectiveness of an AI-generated therapeutic storytelling video on pre-procedural anxiety and fear levels in children aged 4 to 10 years undergoing their first Skin Prick Test (SPT). The study aims to determine if watching a cognitive preparation video at home prior to the appointment reduces anxiety compared to standard care. Participants will be randomized into two groups: an intervention group watching the AI-generated video and a control group receiving standard clinic care",[176,177,178,179],"Anxiety","Fear Anxiety","Allergic Rhinitis","Asthma (Diagnosis)",[181,182,183,184],"Skin Prick Test","Artificial Intelligence","Cognitive Preparation","Storytelling","2026-03-16",{"date":187,"type":38},"2026-03-18",{"date":189,"type":38},"2026-03-15",{"date":191,"type":21},"2026-09-15",{"name":44,"class":45},{"id":194,"slug":195,"hasResults":11,"nctId":196,"briefTitle":197,"officialTitle":197,"acronym":4,"eligibilityCriteria":198,"healthyVolunteers":11,"sex":16,"minAge":199,"maxAge":54,"enrollmentInfo":200,"targetDuration":4,"studyType":22,"phases":201,"briefSummary":202,"conditions":203,"keywords":205,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":185,"lastUpdatePostDateStruct":209,"startDateStruct":210,"completionDateStruct":212,"leadSponsor":214,"locationsCount":4},"100629910","the-effect-of-the-dash-diet-on-clinical-and-metabolic-parameters-in-children-with-masld-100629910","NCT07480811","The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD","Inclusion Criteria:\n\n* Eligibility criteria include being between 11 and 18 years of age,\n* Having a body mass index (BMI) ≥95th percentile,\n* Having hepatic steatosis detected by magnetic resonance imaging (MRI) and proton density fat fraction (PDFF) measurement (cutoff value ≥5%).\n\nExclusion Criteria:\n\n* Other liver diseases (such as viral hepatitis, autoimmune hepatitis, Wilson's disease),\n* Alcohol consumption,\n* History of type I or type II diabetes,\n* Use of medications that may affect fatty liver or blood lipid profile (corticosteroids, metformin, vitamin E, omega-3 fatty acids, etc.),\n* Having participated in a weight loss program or undergone bariatric surgery prior to the study,\n* Presence of chronic inflammatory disease, thyroid dysfunction (hyperthyroidism and hypothyroidism),\n* Having received antibiotic treatment and used nutritional supplements in the last 3 months prior to the study,\n* Having a psychiatric disorder that may affect adherence to the diet or the safety of exercise.","11 Years",{"count":88,"type":21},[24],"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in childhood is becoming increasingly prevalent, paralleling the rise in obesity rates, and has become the most common chronic liver disease in the pediatric population. MASLD is associated with metabolic mechanisms such as insulin resistance, dyslipidemia, oxidative stress, and inflammation, and can progress to serious complications like steatohepatitis, fibrosis, and cirrhosis in later stages. Currently, pharmacological treatments for managing MASLD are limited, and lifestyle modifications, particularly dietary interventions, stand out as the primary approach for preventing and treating the disease. In this context, the composition of macro and micronutrients plays a critical role in the development and progression of hepatic steatosis.\n\nWithin this framework, the Dietary Approaches to Stop Hypertension (DASH) diet is a balanced eating pattern that encourages the consumption of vegetables, fruits, whole grains, legumes, low-fat dairy products, fish, poultry, and healthy fat sources, while limiting sodium, saturated fat, sugary foods, and processed meat products. Similar to the Mediterranean diet, the DASH diet is a promising approach for conditions like metabolic syndrome and MASLD due to its anti-inflammatory potential, its reducing effect on oxidative stress, and its properties that enhance insulin sensitivity. Furthermore, thanks to its high fiber content, it contributes to balancing the gut microbiota and supports the production of short-chain fatty acids (SCFAs), which in turn have positive effects on liver and metabolic health.\n\nEvaluated in terms of fat intake, the DASH diet's emphasis on foods rich in n-3 fatty acids (such as fish and walnuts) provides an anti-inflammatory effect, while limiting saturated and trans fats offers an important strategy for reducing hepatic fat accumulation. Additionally, restricting the consumption of added sugars and fructose may be effective in preventing hepatic steatosis by suppressing lipogenesis processes.\n\nIn light of all these scientific findings, considering the impact of dietary patterns on the development and progression of MASLD, appropriately structuring the diet is critically important for protecting liver health in children. Accordingly, an anti-inflammatory, antioxidant, and metabolically balanced DASH dietary model is considered an effective and applicable approach in the management of pediatric MASLD.\n\nWithin the scope of this study, the effects of implementing the DASH diet in children with MASLD on clinical and metabolic parameters such as liver enzymes, degree of hepatic steatosis, insulin resistance, lipid profile, and inflammatory markers will be evaluated compared to a control group. Additionally, by examining the relationships between these parameters and quality of life as well as dietary adherence, the potential therapeutic role of the DASH diet in the management of pediatric MASLD will be elucidated.",[204],"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)",[206,207,208],"MASLD","Diet modification","DASH Diet",{"date":187,"type":38},{"date":211,"type":21},"2026-04-05",{"date":213,"type":21},"2026-12-30",{"name":44,"class":45},{"id":216,"slug":217,"hasResults":11,"nctId":218,"briefTitle":219,"officialTitle":220,"acronym":4,"eligibilityCriteria":221,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":17,"enrollmentInfo":222,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":224,"conditions":225,"keywords":232,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":238,"lastUpdatePostDateStruct":239,"startDateStruct":241,"completionDateStruct":243,"leadSponsor":245,"locationsCount":79},"100617250","predicting-difficult-intubation-in-bariatric-surgery-comparison-of-el-ganzouri-risk-index-and-airway-ultrasound-100617250","NCT07316179","Predicting Difficult Intubation in Bariatric Surgery: Comparison of El Ganzouri Risk Index and Airway Ultrasound","A Prospective Observational Study Comparing the El Ganzouri Risk Index and Airway Ultrasonography in Predicting Difficult Intubation in Patients Undergoing Bariatric Surgery","Inclusion Criteria:\n\n* Adult patients aged 18 to 65 years.\n* ASA physical status classification II or III.\n* Scheduled to undergo elective bariatric surgery under general anesthesia.\n* Patients who voluntarily agree to participate in the study and sign the informed consent form.\n\nExclusion Criteria:\n\n* Patients younger than 18 years or older than 65 years\n* Presence of upper airway anatomical pathology\n* History of tracheal or thyroid surgery.\n* History of radiotherapy to the head and neck region.\n* Cervical spine anomalies.\n\nIndividuals unwilling to participate in the study.",{"count":223,"type":21},52,"This study is designed as a prospective observational study and will be conducted at the Health Sciences University Antalya Training and Research Hospital. Adult patients scheduled to undergo bariatric surgery will be included.\n\nThe aim of this study is to compare the El Ganzouri Risk Index (EGRI) and airway ultrasonography (USG) parameters in predicting difficult intubation and to evaluate their relationship with the Cormack-Lehane (CL) score obtained during direct laryngoscopy.\n\nBefore surgery, each participant will be evaluated using both the EGRI scoring system and airway USG. During general anesthesia, tracheal intubation will be performed using direct laryngoscopy, and data including the CL score, intubation time, number of attempts, and the need for videolaryngoscopy will be recorded based on the anesthesiologist's observations.\n\nThe collected data will be analyzed by classifying participants according to the presence or absence of difficult intubation, and statistical comparisons will be performed between EGRI scores and airway ultrasonography parameters. The results of this study may contribute to improved preoperative airway assessment and enhanced patient safety in bariatric surgery.",[226,227,228,229,230,231],"Obesity & Overweight","Obesity Difficult Airway Airway Management","Obesity (Disorder)","Difficult Airway","Difficult Intubation in Obesity","Difficult Laryngoscopy",[233,234,235,236,237],"El Ganzouri Risk Index","Difficult airway","Obesity","Airway Ultrasonography","Airway Management","2026-03-06",{"date":240,"type":38},"2026-03-09",{"date":242,"type":38},"2025-12-25",{"date":244,"type":21},"2026-07-28",{"name":44,"class":45},{"id":247,"slug":248,"hasResults":11,"nctId":249,"briefTitle":250,"officialTitle":251,"acronym":4,"eligibilityCriteria":252,"healthyVolunteers":11,"sex":253,"minAge":54,"maxAge":4,"enrollmentInfo":254,"targetDuration":256,"studyType":58,"phases":4,"briefSummary":257,"conditions":258,"keywords":261,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":264,"lastUpdatePostDateStruct":265,"startDateStruct":267,"completionDateStruct":268,"leadSponsor":270,"locationsCount":79},"100618984","does-ultrasound-guidance-axillary-incision-improve-sentinel-lymph-node-detection-in-breast-cancer-100618984","NCT07338721","Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer?","Does Using Ultrasound Guidance During Axillary Incision Improve Sentinel Lymph Node Detection Compared to Standard Methods in Breast Cancer Patients?","Inclusion Criteria:\n\n* \\* Patients with clinical stage T1-T3 disease (tumor ≤5 cm), pN0-pN1 (one to three regional lymph nodes with micrometastases or metastases), and M0 (no distant metastasis) are eligible. Post-neoadjuvant yT1-T3, yN0-yN1, and M0 status are also eligible. All patients are undergoing axillary staging.\n* Clinically negative axilla\n* Written informed consent must be obtained prior to inclusio\n\nExclusion Criteria:\n\n* Younger than 18 years\n* Previous breast malignancy\n* Pregnancy\n* Pre-operative diagnosis of axillary lymph node metastases\n* The presence of multiple clinically involved or suspicious lymph nodes\n* Unable or unwilling to provide informed consent.","FEMALE",{"count":255,"type":21},40,"2 Weeks","This single-center randomized controlled trial evaluates whether detecting the first lymph node at the axillary entrance with ultrasound guidance, followed by a targeted axillary incision over the pencil-marked projection, improves sentinel lymph node identification compared to the conventional axillary hairline landmark. The study hypothesizes that this technique enables a smaller incision, minimizes tissue dissection, and reduces operative time.",[259,260],"Breast Carcinoma","Sentinel Lymph Node Biopsy",[262,263,260,151],"Breast cancer","Axilla","2026-01-14",{"date":266,"type":38},"2026-01-15",{"date":158,"type":38},{"date":269,"type":21},"2026-06-15",{"name":44,"class":45},{"id":272,"slug":273,"hasResults":11,"nctId":274,"briefTitle":275,"officialTitle":276,"acronym":4,"eligibilityCriteria":277,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":4,"enrollmentInfo":278,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":279,"conditions":280,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":283,"lastUpdatePostDateStruct":284,"startDateStruct":286,"completionDateStruct":288,"leadSponsor":290,"locationsCount":4},"100602532","prognostic-power-of-the-vexus-score-in-septic-shock-effectiveness-in-mortality-prediction-100602532","NCT07124741","Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction","Prognostic Power of the VEXUS Score in Septic Shock: Efficacy in Mortality Prediction","Inclusion Criteria:\n\n* Age\\>18\n* Patients monitored for septic shock in intensive care unit\n* Signed informed consent\n\nExclusion Criteria:\n\n* Age \\\u003C18\n* Severe obesity precluding adequate ultrasonographic imaging.\n* Patients in whom venous structures cannot be clearly assessed via ultrasonography due to anatomical or technical reasons (e.g., adhesions following abdominal surgery).\n* Patients receiving dialysis due to chronic kidney disease or initiating dialysis for acute kidney failure.\n* Chronic heart failure.\n* Patients with advanced valvular insufficiency or advanced pulmonary hypertension.\n* Patients with portal hypertension or advanced-stage liver cirrhosis.\n* Presence of acute or chronic thrombosis in the inferior vena cava or other venous structures within the scoring area.\n* Refusal to participate",{"count":172,"type":21},"This study aims to evaluate the prognostic power of the VEXUS Score in predicting mortality among patients with septic shock in intensive care units.",[281,282],"Septic Shock","VExUS","2025-08-14",{"date":285,"type":38},"2025-08-15",{"date":287,"type":21},"2026-03-30",{"date":289,"type":21},"2026-08",{"name":44,"class":45},""]